BioCatalystWatch
CRBPWorkspace / CRBP / OverviewCompany library
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Website

Price
Market cap
Next catalystQ1 2027; previously described as early Q1Sutantatug envedotin + pembrolizumab — first-line OPSCC · Phase 1 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

Sutantatug envedotinSutantatug envedotin + pembrolizumab — first-line OPSCC

Nectin-4

PreINDP1P2P3FilingApproved
Upcoming / outlook

CRB-913

CB1

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Sutantatug envedotinSutantatug envedotin + pembrolizumab — first-line OPSCC

Nectin-4

PreINDP1P2P3FilingApproved
Upcoming / outlook

CRB-913

CB1

PreINDP1P3FilingApproved
Upcoming / outlook

Other pipelines

Sutantatug envedotin

Nectin-4

PreINDP1P2P3FilingApproved
Sutantatug envedotin

Nectin-4

PreINDP1P2P3FilingApproved
CRB-913

CB1

PreINDP1P2P3FilingApproved

CRB-556

CB1

PreINDP1P2P3FilingApproved

History / paused

Integrin αvβ8

PreINDP1P2P3FilingApproved

CB1

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CRBP PR & News

PR & News

CRBP SEC archive